2026-07-17 Posted by TideChem view:21
An amino acid is the basic building block of protein. Amino acids join together through peptide bonds to form peptides and polypeptide chains. These chains then fold, undergo processing and sometimes associate with other chains to become functional proteins.
Most proteins are assembled from 20 commonly occurring amino acids. Their different side chains give proteins an enormous range of structures and functions, from enzymes and antibodies to receptors, hormones and structural materials.
For researchers and pharmaceutical professionals, amino acids are more than basic biological monomers. They are raw materials for peptide synthesis, tools for protein engineering, formulation components and starting points for many therapeutic molecules.
An amino acid is an organic molecule containing both an amino group and a carboxyl group. The amino acids incorporated into proteins are primarily alpha-amino acids, meaning that both functional groups are connected to the same central carbon atom.
A typical alpha-amino acid contains:
The R group distinguishes one amino acid from another. It determines properties such as molecular size, charge, polarity, hydrophobicity and chemical reactivity.
Glycine has a hydrogen atom as its side chain and is the smallest proteinogenic amino acid. Tryptophan has a much larger aromatic side chain. Aspartic acid contains an acidic group, while lysine contains a basic amino group.
These structural differences explain how a relatively small set of monomers can generate proteins with highly diverse properties.
Proteins are biological polymers, and amino acids are their monomeric units. During protein formation, the amino group of one amino acid becomes connected to the carboxyl group of another.
Repeated bond formation produces a chain of amino acid residues called a polypeptide.
The relationship can be summarized as follows:
Amino acids → peptides → polypeptide chains → folded proteins
Once an amino acid is incorporated into a peptide or protein, it is commonly called an amino acid residue. The term reflects the fact that it has become part of a larger covalent structure.
According to OpenStax Biology, proteins are polymers of amino acids arranged in linear sequences, and the side chain of each amino acid determines its chemical nature.
The central alpha carbon provides the structural framework shared by nearly all standard proteinogenic amino acids.
In aqueous solution near physiological pH, the amino group is usually protonated and carries a positive charge, while the carboxyl group is deprotonated and carries a negative charge. A molecule containing both positive and negative charges is called a zwitterion.
The actual charge of an amino acid depends on pH and the ionizable groups in its side chain. This property is important in electrophoresis, chromatography, protein purification and formulation development.
With the exception of glycine, standard amino acids have a chiral alpha carbon. Proteins synthesized by ribosomes are built predominantly from L-amino acids.
D-amino acids may occur in certain natural products, bacterial cell-wall components and engineered peptides, but they are not normally incorporated through standard ribosomal translation.
The 20 amino acids commonly used to build proteins are:
These amino acids can be grouped according to the chemical properties of their side chains. However, classification systems vary because some residues fit into more than one category.
Nonpolar residues tend to avoid water and often become buried inside folded proteins. Examples include alanine, valine, leucine, isoleucine and methionine.
Hydrophobic interactions among these residues are a major driving force in protein folding.
Polar uncharged residues can form hydrogen bonds but normally carry no net side-chain charge near physiological pH. Examples include serine, threonine, asparagine and glutamine.
These residues are often found at protein surfaces, enzyme active sites and molecular recognition interfaces.
Aspartic acid and glutamic acid usually carry negatively charged side chains near physiological pH.
They participate in ionic interactions, metal coordination, catalysis and pH-dependent protein behavior.
Lysine and arginine commonly carry positive side-chain charges. Histidine can change protonation state within a biologically relevant pH range.
Basic residues frequently interact with negatively charged molecules such as DNA, RNA, phospholipids and phosphorylated proteins.
Phenylalanine, tyrosine and tryptophan contain aromatic ring systems. These residues can contribute to hydrophobic packing, molecular recognition and ultraviolet absorption.
Tyrosine can also undergo phosphorylation, while tryptophan is particularly useful for monitoring protein concentration and folding through fluorescence spectroscopy.
Cysteine and methionine contain sulfur.
Cysteine residues can form disulfide bonds that stabilize protein structure. Methionine is often the first amino acid incorporated during translation, although the initial methionine may later be removed.
The standard explanation focuses on 20 genetically encoded amino acids, but biology includes important exceptions.
Selenocysteine is sometimes called the 21st amino acid. It can be incorporated into selected proteins through specialized recoding of a stop codon.
Pyrrolysine is sometimes called the 22nd amino acid. It occurs in certain archaea and bacteria and also requires specialized translation machinery.
Proteins can additionally contain residues produced through post-translational modification. Hydroxyproline in collagen is a familiar example. It is formed by modifying proline after the polypeptide has been synthesized.
In pharmaceutical research, non-natural amino acids can be introduced through chemical synthesis, engineered translation systems or protein modification.
The terms essential and nonessential describe human nutrition and metabolism. They do not indicate whether an amino acid can be incorporated into a protein.
An essential amino acid cannot be produced by the human body in sufficient amounts and must be obtained from the diet. Nine amino acids are generally considered essential for healthy adults:
Nonessential amino acids can normally be synthesized by the body. Conditionally essential amino acids may need to be supplied in greater amounts during illness, injury, growth or metabolic stress.
Both essential and nonessential amino acids can serve as protein building blocks. The classification concerns their source, not their ability to form proteins. Further background is available from the NCBI Bookshelf.
Amino acids are connected by peptide bonds. A peptide bond is a covalent amide linkage between the carboxyl-derived carbonyl carbon of one amino acid and the nitrogen of the next.
Peptide-bond formation can be represented formally as a condensation reaction involving the loss of elements corresponding to water.
The peptide bond has partial double-bond character and is relatively rigid and planar. Most polypeptide flexibility comes from rotation around the bonds adjacent to the alpha carbon.
A growing chain has two different ends:
Protein and peptide sequences are written from the N-terminus to the C-terminus.
Cells build polypeptide chains through translation. Messenger RNA carries a nucleotide sequence copied from DNA, and a ribosome reads that sequence in groups of three nucleotides called codons.
Transfer RNA molecules deliver the amino acids corresponding to each codon. Before translation, aminoacyl-tRNA synthetases attach the correct amino acids to their transfer RNAs.
The ribosome then transfers the growing peptide chain to the incoming amino acid. Each new residue is added to the C-terminal end, so biological protein synthesis proceeds from the N-terminus toward the C-terminus.
When a stop codon is reached, the completed polypeptide is released. It may begin folding during translation, but many proteins require further processing before they become active.
An overview of ribosomal protein production is available from OpenStax Biology 2e.
The linear order of amino acids is the primary structure of a protein. That sequence influences all higher levels of organization.
Secondary structure includes local arrangements such as alpha helices, beta sheets and turns. These structures are stabilized mainly by hydrogen bonds involving the polypeptide backbone.
Tertiary structure describes the complete three-dimensional folding of one polypeptide chain. Hydrophobic interactions, hydrogen bonds, ionic interactions, van der Waals forces and disulfide bonds contribute to this structure.
Quaternary structure occurs when multiple polypeptide chains associate to form a functional protein.
Amino acid sequence is a primary determinant of folding, but the cellular or formulation environment also matters. Temperature, pH, ionic strength, solvent composition and molecular chaperones can influence the final conformation.
A peptide is a relatively short chain of amino acid residues. A polypeptide is usually longer, although there is no universally accepted numerical boundary.
A protein is a functional biological structure composed of one or more folded polypeptide chains. It may also contain glycans, metal ions, lipids or other non-polypeptide components.
Not every polypeptide is automatically a complete protein. It may be an unfolded chain, precursor, protein subunit or synthetic sequence without an established biological function.
Proteins can contain one chain or several chains. Insulin contains two peptide chains connected by disulfide bonds, while a conventional monoclonal antibody contains two heavy chains and two light chains.
Many polypeptides undergo post-translational modifications that expand the chemical diversity available from the standard amino acid building blocks.
Common modifications include:
These modifications can affect activity, stability, localization, protein-protein interactions and circulating half-life.
For recombinant therapeutics, post-translational modifications are critical quality attributes. Changes in expression system or manufacturing conditions can alter glycosylation, disulfide connectivity and other product characteristics even when the encoded amino acid sequence remains unchanged.
Chemical peptide synthesis usually uses protected amino acid derivatives rather than unprotected amino acids.
In Fmoc solid-phase peptide synthesis, the growing peptide is attached to a resin. The temporary Fmoc protecting group is removed before each coupling cycle, while reactive side chains remain protected until chain assembly is complete.
Conventional solid-phase synthesis proceeds from the C-terminus toward the N-terminus, which is opposite to ribosomal translation.
The quality of protected amino acid building blocks directly affects synthesis performance. Important attributes include:
Poor-quality starting materials can contribute to failed coupling, racemization, deletion sequences and difficult purification.
Non-natural amino acids expand the chemical possibilities beyond the standard proteinogenic set.
They may be introduced to improve:
Examples include D-amino acids, N-methyl amino acids, beta-amino acids, alpha-methyl amino acids and residues containing bioorthogonal reactive groups.
A single non-natural residue can substantially change peptide behavior. However, it can also increase synthesis difficulty, alter impurity profiles and require additional analytical characterization.
Amino acids may also be used as formulation excipients rather than as covalent parts of the active protein.
Histidine can act as a buffering component. Arginine is used in some formulations to influence solubility and aggregation. Glycine may function as a stabilizer, tonicity modifier or lyoprotective component.
The effect of an amino acid excipient depends on concentration, pH, ionic strength and the properties of the therapeutic molecule. An amino acid that improves one formulation may be ineffective or destabilizing in another.
Excipient selection should therefore be supported by formulation screening and stability studies.
Protein and peptide quality can change during production, purification, storage and administration.
Oxidation may affect methionine, cysteine, tryptophan, tyrosine and histidine. Asparagine and glutamine can undergo deamidation, while aspartic acid residues may isomerize.
Cysteine residues can form incorrect disulfide bonds. Chemical peptide synthesis may introduce racemization, incomplete coupling or side-chain modification.
These changes can affect potency, solubility, folding, receptor binding, pharmacokinetics and immunogenicity.
The importance of a particular modification depends on its location. An altered residue at an active site or binding interface is generally more likely to affect function than a modification in a noncritical surface region.
Amino acid analysis can determine composition and support protein or peptide content measurements.
Chiral chromatography may be used to evaluate enantiomeric purity, especially for synthetic amino acid building blocks and non-natural residues.
Mass spectrometry can confirm molecular mass and detect many sequence variants or modifications. Peptide mapping combines controlled protein digestion with chromatography and mass spectrometry to provide detailed sequence coverage.
Reversed-phase HPLC and UPLC are commonly used to assess peptide purity. Size-exclusion chromatography can detect protein fragments and soluble aggregates.
Circular dichroism, fluorescence spectroscopy and other biophysical methods provide information about protein folding. Biological assays are required when the objective is to confirm function or potency.
No single method establishes complete identity, purity, structure and activity. Reliable characterization uses complementary analytical techniques.
Most proteins contain many different amino acids arranged in a defined sequence.
They share a common backbone, but their side chains differ greatly in charge, size, polarity and reactivity.
Both essential and nonessential amino acids are incorporated into proteins. Essential refers to dietary requirements.
The primary chain is held together by covalent peptide bonds. Hydrogen bonds contribute mainly to folding and higher-order structure.
Many residues are chemically modified after translation. Non-natural residues can also be introduced through synthetic or engineered methods.
Sequence identity is fundamental, but correct folding, modification, assembly and conformation are also required.
The basic building block of protein is the amino acid. Amino acids connect through peptide bonds to form polypeptide chains.
Most proteins are built from 20 common proteinogenic amino acids. Selenocysteine and pyrrolysine are additional genetically encoded amino acids used in specialized biological systems.
The side chain, or R group, varies among amino acids and determines many of their chemical properties.
A covalent peptide bond joins the carboxyl-derived group of one amino acid to the amino-derived nitrogen of the next.
Yes. Both are composed of amino acid residues. They differ in length, structure, processing and functional organization.
Sequence influences protein folding, stability, molecular interactions and biological activity. Even one substitution can alter function.
Ribosomally produced proteins are built mainly from L-amino acids. D-amino acids are found in certain biological structures and can be introduced into synthetic peptides.
Yes. Non-natural amino acids are widely investigated to improve stability, selectivity, potency and resistance to enzymatic degradation.
An amino acid is the fundamental building block of protein. Amino acids connect through peptide bonds to form ordered polypeptide chains, and those chains fold and mature into functional proteins.
Their side-chain diversity gives proteins their wide range of chemical and biological properties. In pharmaceutical research, amino acids also support peptide synthesis, protein engineering, formulation development and therapeutic optimization.
Understanding amino acid structure, stereochemistry, bonding and degradation is therefore essential for both basic life-science research and modern biopharmaceutical development.